1.Evidence-based research on disability studies in China using VOSviewer
Shuai GUO ; Yihao ZHAO ; Shangjun LIU ; Xiaoying ZHENG
Chinese Journal of Rehabilitation Theory and Practice 2023;29(3):302-311
ObjectiveTo review the development history of research on people with disabilities, summarize the patterns, characteristics and deficiencies in this discipline, and make suggestions for discipline development in the future. MethodsThe literature about disability from 1986 to 2018 were searched and retrieved on the CNKI. Valid literature were selected based on the title and abstract. Descriptive analyses were used to analyze the development of research on people with disabilities in China. VOSviewer was used to explore the cooperation among researchers and research hotspots in this field. ResultsA total of 2 267 papers were included. Researches on people with disabilities in China started in 1986 and then experienced rapid development driven by survey data, showing obvious stage characteristics. The foundation of academic cooperation networks has been formed initially, showing the comprehensive development of multiple themes. However, in the new stage, the lack of follow-up support for research infrastructure conditions, as well as the slow innovation of research theories and expansion of research contents may become key factors hindering the further development of the discipline. ConclusionThe research foundation should be consolidated in the future, including broadening cooperation and communication channels, strengthening disability statistics, and promoting cross-disciplinary research. Theoretical research should be strengthened by standardizing research methods and finding internalized theoretical innovation points combining the national conditions. Finally, research content should be enriched, especially by closely combining the current changes in the needs of people with disabilities and strengthening the research on disability prevention and control, health promotion, social integration, and social management of the people with disabilities.
2.Effect of CCL3 on osteoblast in myeloma bone disease.
Sijie ZHAO ; Rong FU ; Hui LIU ; Yihao WANG ; Lijuan LI ; Chunyan LIU ; Tian ZHANG ; Shaoxue DING ; Shan GAO ; Erbao RUAN ; Wen QU ; Huaquan WANG ; Xiaoming WANG ; Yuhong WU ; Jia SONG ; Hong LIU ; Jing GUAN ; Zonghong SHAO
Chinese Journal of Hematology 2014;35(7):623-627
OBJECTIVETo culture osteoblast in vitro and evaluate CCL3 receptor CCR1 expression in patients with multiple myeloma (MM).
METHODSBone marrow osteoblasts from MM patients were cultured in vitro with dexamethasone, β-sodium glycerophosphate and vitamin C, which were identified by alkaline phosphatase staining, Von Kossa's staining. The CCL3 receptor expression was evaluated by flow cytometry. The morphology and quantity of osteoblast were observed after exposure to CCL3.
RESULTSBone marrow osteoblasts from MM patients could be cultured in vitro and be identified by positive staining of alkaline phosphatase and Von Kossa's. MM-derived osteoblasts expressed higher levels of CCR1 (74.48 ± 7.31)%, compared with normal controls (48.35 ± 8.81)%. Calcium deposition of osteoblasts after exposure to CCL3 was less than that of controls.
CONCLUSIONBone marrow osteoblasts could be cultured in vitro from MM Patients. CCL3 may contribute to the development of myeloma bone disease.
Adult ; Aged ; Cells, Cultured ; Chemokine CCL3 ; pharmacology ; Female ; Humans ; Male ; Middle Aged ; Multiple Myeloma ; pathology ; Osteoblasts ; cytology ; drug effects ; metabolism ; Receptors, CCR1 ; metabolism ; Young Adult
3.Preparation and Study on in vitro Transdermal Characteristics of Tetramethylpyrazine Pellicle
Ying WANG ; Yanan HE ; Yihao CHE ; Shimeng YUAN ; Hairong ZHAO ; Xiumei WU ; Zhibin YANG
China Pharmacy 2020;31(2):160-164
OBJECTIVE:To preliminarily optimize the preparation technology of Ligustrazine pellicle ,and to study its in vitro percutaneous permeation characteristics. METHODS :With the amounts of PVA- 124,ethyl alcohol ,glycerin,tween-80 and azone as factors ,single factor experiment was used to optimize the Ligustrazine pellicle matrix formulation ;modified scoring standard was used to evaluate the film formation time ,film formation ability ,ductility,uniformity and the presence of bubble. On the basis of the optimal matrix formulation ,the pellicle with different loading amount of ligustrazine (300,250,200,150,100,50 mg/mL) was prepared and its maximum loading amount was investigated. HPLC method was adopted to determine the content of ligustrazine,and methodology investigation was conducted. Isolated back skin of rats were collected ,the percutaneous permeation test was conducted for high ,medium and low loading amount (100,75,50 mg/mL)of Ligustrazine pellicle. At 15,30,45,60, 75,90,120,150,180 min,the sample was taken and the permeation rate of ligustrazine was calculated. RESULTS :When the amounts of PVA- 124,ethyl alcohol,glycerin,tween-80 and azone were 2.5 g,7.0 mL,1.97 mL,0.07 mL,0.28 mL(in terms of 50 mL formulation amount ),the optimal matrix formulation of Ligustrazine pellicle was obtained. The maximum drug loading amount of ligustrazine was 100 mg/mL. The linear ranges of ligustrazine was 3.125-100 μg/mL. The specificity,precision, reproducibility,recovery and stability investigation of content determination method of ligustrazine were all in line with the requirements(RSD<2%). The permeation rate of high ,medium and low loading amount of Ligustrazine pellicle were 608.42, 384.19,158.20 μg(/ cm2·h). CONCLUSIONS :According to the optimized formulation ,the prepared Ligustrazine pellicle had a short film forming time ,stable and re liable quality ; the drug-loading amount was up to 100 mg/mL. The pellicle with drug-loading amount of 75 mg/mL had reached the penetration rate range of effective plasma concentration of ligustrazine treatment.